+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Implantable Drug Eluting Balloon Market - Global Forecast 2026-2032- Product Image
Implantable Drug Eluting Balloon Market - Global Forecast 2026-2032- Product Image
Sale

Implantable Drug Eluting Balloon Market - Global Forecast 2026-2032

  • Report

  • 194 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6123947
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Implantable Drug Eluting Balloon Market is projected to reach USD 1.34 Billion in 2026. It is expected to continue growing at a CAGR of 7.86%, reaching USD 2.13 Billion by 2032.

Implantable Drug-Eluting Balloons: Executive Overview

Implantable drug-eluting balloons combine balloon-based delivery with localized pharmacological therapy, targeting diseased vessels or other anatomies while seeking to reduce systemic exposure. The field remains clinically and technically specialized, with adoption shaped by evidence quality, procedural fit, reimbursement, device durability, and regulatory requirements. Evaluation should distinguish temporary drug-coated balloon procedures from genuinely implantable or bioresorbable balloon concepts, because their risk profiles, mechanisms, and clinical endpoints differ substantially.

Clinical and Technical Shifts Redefining the Field

The landscape is moving toward more precise drug delivery, improved material compatibility, and stronger integration with image-guided intervention. Development priorities include controlled drug release, reliable expansion and positioning, reduced injury during deployment, and designs that limit thrombosis, inflammation, and late vessel compromise. Translational progress depends on demonstrating durable clinical benefit rather than only technical success, particularly in complex lesions and patients with substantial comorbidity.

Artificial Intelligence Strengthens Design, Selection, and Follow-Up

Artificial intelligence can support this field through image interpretation, lesion characterization, procedural planning, and post-procedure surveillance. Machine-learning models may help identify patients most likely to benefit from localized drug delivery, estimate restenosis risk, and flag imaging patterns associated with complications. However, clinical value depends on representative training data, external validation, explainability, cybersecurity, and prospective evidence showing that algorithmic support improves outcomes without introducing inequity or workflow burden.

Regional Insights Across Six Distinct Health-System Contexts

North America is characterized by sophisticated interventional infrastructure, demanding evidence standards, and strong attention to reimbursement and post-market surveillance. Europe emphasizes conformity assessment, clinical evidence, and cross-border health-technology evaluation, while Asia-Pacific combines advanced tertiary centers with highly varied access and regulatory pathways. Latin America is influenced by public procurement, import dependence, and uneven specialist availability. The Middle East is developing specialized hospital capacity, particularly in major urban systems, while Africa faces broader constraints in imaging, trained personnel, procurement continuity, and follow-up care. Across all regions, successful deployment requires localized training, reliable supply chains, and evidence relevant to local patient populations.

Group Insights: Policy and Collaboration Shape Adoption

ASEAN markets differ substantially in regulatory maturity, reimbursement, and hospital capability, making regional harmonization and distributor quality controls important. BRICS members combine large and diverse patient populations with varying domestic manufacturing capacity, approval processes, and public-sector purchasing models. The European Union benefits from integrated scientific and regulatory collaboration but must navigate country-level reimbursement decisions. G7 systems generally apply stringent clinical, safety, and quality expectations. GCC countries often concentrate advanced care in referral hospitals and can accelerate adoption through coordinated procurement. NATO members span diverse health systems, yet interoperability, resilient logistics, and high standards for device assurance remain common priorities.

Country Insights: Evidence and Access Priorities

Australia emphasizes health-technology assessment, specialist expertise, and geographically dispersed access. Brazil and Mexico must address public-sector affordability, import logistics, and regional disparities in specialist care. Canada and the United States place substantial weight on clinical evidence, regulatory compliance, procedural economics, and post-market monitoring. China and India combine major clinical capacity with significant variation between leading urban hospitals and less-resourced settings. Japan and South Korea prioritize technical quality, aging-population needs, and rigorous clinical practice. France, Germany, Italy, Spain, and the United Kingdom assess evidence, reimbursement, and service capacity through distinct national or devolved pathways; Germany and France are particularly relevant for structured hospital evaluation, while the United Kingdom emphasizes health-system value and implementation evidence. Russia’s deployment environment is shaped by regulatory access, procurement conditions, and continuity of specialized supplies.

Priorities for Leaders: Prove Value Before Scaling

Industry leaders should first define the precise clinical indication and differentiate the device clearly from temporary drug-coated balloon technologies. They should generate prospective, independently adjudicated evidence with meaningful follow-up, prespecified safety endpoints, and subgroup analysis for complex anatomy and high-risk patients. Development programs should incorporate human-factors testing, imaging-based guidance, manufacturing controls, cybersecurity where applicable, and transparent reporting of drug-release behavior. Commercial and clinical teams should engage regulators, payers, physicians, and patient representatives early; build training and proctoring systems; establish registries for long-term surveillance; and tailor implementation plans to regional infrastructure rather than assuming uniform access.

Research Methodology: Structured Interpretation of the Reference Market

This executive summary uses the supplied market title and required geographic groupings as the scope of analysis. It applies a qualitative framework covering clinical need, device engineering, evidence generation, regulation, reimbursement, workforce capability, infrastructure, supply continuity, and digital-health integration. The assessment avoids market estimates, shares, forecasts, and company-level claims. Regional, group, and country observations are presented as contextual considerations and should be validated against current regulatory documents, peer-reviewed clinical literature, procurement policies, and local health-technology assessments before operational decisions are made.

Conclusion: Evidence, Safety, and Implementation Will Determine Progress

Implantable drug-eluting balloons represent a specialized convergence of interventional therapy, biomaterials, and localized pharmacology. Their advancement will depend less on novelty alone than on reproducible deployment, durable patient benefit, manageable safety risks, and credible economic value within real clinical workflows. Leaders that align engineering with rigorous clinical evidence, responsible artificial-intelligence use, regional implementation planning, and long-term surveillance will be better positioned to support safe and sustainable adoption.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Implantable Drug Eluting Balloon Market, by Indication
7.1. Introduction
7.2. De Novo Lesion
7.2.1. Coronary Artery Disease
7.2.2. Peripheral Artery Disease
7.3. In-Stent Restenosis
8. Implantable Drug Eluting Balloon Market, by Product Type
8.1. Introduction
8.2. Coronary
8.3. Peripheral
9. Implantable Drug Eluting Balloon Market, by Drug Type
9.1. Introduction
9.2. Paclitaxel
9.3. Sirolimus
10. Implantable Drug Eluting Balloon Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Cardiac Centers
10.4. Hospitals
10.4.1. Private Hospitals
10.4.2. Public Hospitals
11. Implantable Drug Eluting Balloon Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Implantable Drug Eluting Balloon Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Implantable Drug Eluting Balloon Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. Alvimedica Medical Technologies Inc.
15.3. AngioDynamics, Inc.
15.4. B. Braun Melsungen AG
15.5. Becton, Dickinson and Company
15.6. BIOTRONIK SE & Co. KG
15.7. Boston Scientific Corporation
15.8. Cardionovum GmbH
15.9. Concept Medical, Inc.
15.10. ConMed Corporation
15.11. Cook Medical Incorporated
15.12. Eurocor GmbH
15.13. iVascular S.L.U.
15.14. Koninklijke Philips N.V.
15.15. Lepu Medical Technology (Beijing) Co., Ltd.
15.16. Medtronic plc
15.17. MicroPort Scientific Corporation
15.18. Opto Circuits (India) Ltd.
15.19. Paladin Medical Pvt. Ltd.
15.20. Terumo Corporation
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Implantable Drug Eluting Balloon Market, Years Considered for the Study
FIGURE 2. Global Implantable Drug Eluting Balloon Market, Research Design
FIGURE 3. Global Implantable Drug Eluting Balloon Market, Research Framework
FIGURE 4. Global Implantable Drug Eluting Balloon Market, Data Triangulation
FIGURE 5. Global Implantable Drug Eluting Balloon Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Implantable Drug Eluting Balloon Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 7. Global Implantable Drug Eluting Balloon Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Implantable Drug Eluting Balloon Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 9. Global Implantable Drug Eluting Balloon Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Implantable Drug Eluting Balloon Market Size, by Drug Type, 2025 vs 2032 (%)
FIGURE 11. Global Implantable Drug Eluting Balloon Market Size, by Drug Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Implantable Drug Eluting Balloon Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Implantable Drug Eluting Balloon Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Implantable Drug Eluting Balloon Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Implantable Drug Eluting Balloon Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Implantable Drug Eluting Balloon Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Implantable Drug Eluting Balloon Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Implantable Drug Eluting Balloon Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Implantable Drug Eluting Balloon Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Implantable Drug Eluting Balloon Market Segmentation & Coverage
TABLE 2. Global Implantable Drug Eluting Balloon Market Size, 2017-2032 (USD Million)
TABLE 3. Global Implantable Drug Eluting Balloon Market Size, by Indication, 2017-2032 (USD Million)
TABLE 4. Global De Novo Lesion Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global De Novo Lesion Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global De Novo Lesion Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Coronary Artery Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Coronary Artery Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Coronary Artery Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Peripheral Artery Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Peripheral Artery Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Peripheral Artery Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global In-Stent Restenosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global In-Stent Restenosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global In-Stent Restenosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Implantable Drug Eluting Balloon Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 17. Global Coronary Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Coronary Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Coronary Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Peripheral Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Peripheral Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Peripheral Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Implantable Drug Eluting Balloon Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 24. Global Paclitaxel Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Paclitaxel Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Paclitaxel Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Sirolimus Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Sirolimus Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Sirolimus Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Implantable Drug Eluting Balloon Market Size, by End User, 2017-2032 (USD Million)
TABLE 31. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Cardiac Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Cardiac Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Cardiac Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Public Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Public Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Public Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Implantable Drug Eluting Balloon Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Asia-Pacific Implantable Drug Eluting Balloon Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Asia-Pacific Implantable Drug Eluting Balloon Market Size, by Indication, 2017-2032 (USD Million)
TABLE 49. Asia-Pacific Implantable Drug Eluting Balloon Market Size, by De Novo Lesion, 2017-2032 (USD Million)
TABLE 50. Asia-Pacific Implantable Drug Eluting Balloon Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 51. Asia-Pacific Implantable Drug Eluting Balloon Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 52. Asia-Pacific Implantable Drug Eluting Balloon Market Size, by End User, 2017-2032 (USD Million)
TABLE 53. Asia-Pacific Implantable Drug Eluting Balloon Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 54. North America Implantable Drug Eluting Balloon Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. North America Implantable Drug Eluting Balloon Market Size, by Indication, 2017-2032 (USD Million)
TABLE 56. North America Implantable Drug Eluting Balloon Market Size, by De Novo Lesion, 2017-2032 (USD Million)
TABLE 57. North America Implantable Drug Eluting Balloon Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 58. North America Implantable Drug Eluting Balloon Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 59. North America Implantable Drug Eluting Balloon Market Size, by End User, 2017-2032 (USD Million)
TABLE 60. North America Implantable Drug Eluting Balloon Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 61. Latin America Implantable Drug Eluting Balloon Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Latin America Implantable Drug Eluting Balloon Market Size, by Indication, 2017-2032 (USD Million)
TABLE 63. Latin America Implantable Drug Eluting Balloon Market Size, by De Novo Lesion, 2017-2032 (USD Million)
TABLE 64. Latin America Implantable Drug Eluting Balloon Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 65. Latin America Implantable Drug Eluting Balloon Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 66. Latin America Implantable Drug Eluting Balloon Market Size, by End User, 2017-2032 (USD Million)
TABLE 67. Latin America Implantable Drug Eluting Balloon Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 68. Europe Implantable Drug Eluting Balloon Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Europe Implantable Drug Eluting Balloon Market Size, by Indication, 2017-2032 (USD Million)
TABLE 70. Europe Implantable Drug Eluting Balloon Market Size, by De Novo Lesion, 2017-2032 (USD Million)
TABLE 71. Europe Implantable Drug Eluting Balloon Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 72. Europe Implantable Drug Eluting Balloon Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 73. Europe Implantable Drug Eluting Balloon Market Size, by End User, 2017-2032 (USD Million)
TABLE 74. Europe Implantable Drug Eluting Balloon Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 75. Middle East Implantable Drug Eluting Balloon Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Middle East Implantable Drug Eluting Balloon Market Size, by Indication, 2017-2032 (USD Million)
TABLE 77. Middle East Implantable Drug Eluting Balloon Market Size, by De Novo Lesion, 2017-2032 (USD Million)
TABLE 78. Middle East Implantable Drug Eluting Balloon Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 79. Middle East Implantable Drug Eluting Balloon Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 80. Middle East Implantable Drug Eluting Balloon Market Size, by End User, 2017-2032 (USD Million)
TABLE 81. Middle East Implantable Drug Eluting Balloon Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 82. Africa Implantable Drug Eluting Balloon Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Africa Implantable Drug Eluting Balloon Market Size, by Indication, 2017-2032 (USD Million)
TABLE 84. Africa Implantable Drug Eluting Balloon Market Size, by De Novo Lesion, 2017-2032 (USD Million)
TABLE 85. Africa Implantable Drug Eluting Balloon Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 86. Africa Implantable Drug Eluting Balloon Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 87. Africa Implantable Drug Eluting Balloon Market Size, by End User, 2017-2032 (USD Million)
TABLE 88. Africa Implantable Drug Eluting Balloon Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 89. Global Implantable Drug Eluting Balloon Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. ASEAN Implantable Drug Eluting Balloon Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. ASEAN Implantable Drug Eluting Balloon Market Size, by Indication, 2017-2032 (USD Million)
TABLE 92. ASEAN Implantable Drug Eluting Balloon Market Size, by De Novo Lesion, 2017-2032 (USD Million)
TABLE 93. ASEAN Implantable Drug Eluting Balloon Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 94. ASEAN Implantable Drug Eluting Balloon Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 95. ASEAN Implantable Drug Eluting Balloon Market Size, by End User, 2017-2032 (USD Million)
TABLE 96. ASEAN Implantable Drug Eluting Balloon Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 97. GCC Implantable Drug Eluting Balloon Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. GCC Implantable Drug Eluting Balloon Market Size, by Indication, 2017-2032 (USD Million)
TABLE 99. GCC Implantable Drug Eluting Balloon Market Size, by De Novo Lesion, 2017-2032 (USD Million)
TABLE 100. GCC Implantable Drug Eluting Balloon Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 101. GCC Implantable Drug Eluting Balloon Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 102. GCC Implantable Drug Eluting Balloon Market Size, by End User, 2017-2032 (USD Million)
TABLE 103. GCC Implantable Drug Eluting Balloon Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 104. European Union Implantable Drug Eluting Balloon Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. European Union Implantable Drug Eluting Balloon Market Size, by Indication, 2017-2032 (USD Million)
TABLE 106. European Union Implantable Drug Eluting Balloon Market Size, by De Novo Lesion, 2017-2032 (USD Million)
TABLE 107. European Union Implantable Drug Eluting Balloon Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 108. European Union Implantable Drug Eluting Balloon Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 109. European Union Implantable Drug Eluting Balloon Market Size, by End User, 2017-2032 (USD Million)
TABLE 110. European Union Implantable Drug Eluting Balloon Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 111. BRICS Implantable Drug Eluting Balloon Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. BRICS Implantable Drug Eluting Balloon Market Size, by Indication, 2017-2032 (USD Million)
TABLE 113. BRICS Implantable Drug Eluting Balloon Market Size, by De Novo Lesion, 2017-2032 (USD Million)
TABLE 114. BRICS Implantable Drug Eluting Balloon Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 115. BRICS Implantable Drug Eluting Balloon Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 116. BRICS Implantable Drug Eluting Balloon Market Size, by End User, 2017-2032 (USD Million)
TABLE 117. BRICS Implantable Drug Eluting Balloon Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 118. G7 Implantable Drug Eluting Balloon Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. G7 Implantable Drug Eluting Balloon Market Size, by Indication, 2017-2032 (USD Million)
TABLE 120. G7 Implantable Drug Eluting Balloon Market Size, by De Novo Lesion, 2017-2032 (USD Million)
TABLE 121. G7 Implantable Drug Eluting Balloon Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 122. G7 Implantable Drug Eluting Balloon Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 123. G7 Implantable Drug Eluting Balloon Market Size, by End User, 2017-2032 (USD Million)
TABLE 124. G7 Implantable Drug Eluting Balloon Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 125. NATO Implantable Drug Eluting Balloon Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. NATO Implantable Drug Eluting Balloon Market Size, by Indication, 2017-2032 (USD Million)
TABLE 127. NATO Implantable Drug Eluting Balloon Market Size, by De Novo Lesion, 2017-2032 (USD Million)
TABLE 128. NATO Implantable Drug Eluting Balloon Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 129. NATO Implantable Drug Eluting Balloon Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 130. NATO Implantable Drug Eluting Balloon Market Size, by End User, 2017-2032 (USD Million)
TABLE 131. NATO Implantable Drug Eluting Balloon Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 132. Global Implantable Drug Eluting Balloon Market Size, by Country, 2017-2032 (USD Million)
TABLE 133. United States Implantable Drug Eluting Balloon Market Size, 2017-2032 (USD Million)
TABLE 134. United States Implantable Drug Eluting Balloon Market Size, by Indication, 2017-2032 (USD Million)
TABLE 135. United States Implantable Drug Eluting Balloon Market Size, by De Novo Lesion, 2017-2032 (USD Million)
TABLE 136. United States Implantable Drug Eluting Balloon Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 137. United States Implantable Drug Eluting Balloon Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 138. United States Implantable Drug Eluting Balloon Market Size, by End User, 2017-2032 (USD Million)
TABLE 139. United States Implantable Drug Eluting Balloon Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 140. Canada Implantable Drug Eluting Balloon Market Size, 2017-2032 (USD Million)
TABLE 141. Canada Implantable Drug Eluting Balloon Market Size, by Indication, 2017-2032 (USD Million)
TABLE 142. Canada Implantable Drug Eluting Balloon Market Size, by De Novo Lesion, 2017-2032 (USD Million)
TABLE 143. Canada Implantable Drug Eluting Balloon Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 144. Canada Implantable Drug Eluting Balloon Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 145. Canada Implantable Drug Eluting Balloon Market Size, by End User, 2017-2032 (USD Million)
TABLE 146. Canada Implantable Drug Eluting Balloon Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 147. Mexico Implantable Drug Eluting Balloon Market Size, 2017-2032 (USD Million)
TABLE 148. Mexico Implantable Drug Eluting Balloon Market Size, by Indication, 2017-2032 (USD Million)
TABLE 149. Mexico Implantable Drug Eluting Balloon Market Size, by De Novo Lesion, 2017-2032 (USD Million)
TABLE 150. Mexico Implantable Drug Eluting Balloon Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 151. Mexico Implantable Drug Eluting Balloon Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 152. Mexico Implantable Drug Eluting Balloon Market Size, by End User, 2017-2032 (USD Million)
TABLE 153. Mexico Implantable Drug Eluting Balloon Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 154. Brazil Implantable Drug Eluting Balloon Market Size, 2017-2032 (USD Million)
TABLE 155. Brazil Implantable Drug Eluting Balloon Market Size, by Indication, 2017-2032 (USD Million)
TABLE 156. Brazil Implantable Drug Eluting Balloon Market Size, by De Novo Lesion, 2017-2032 (USD Million)
TABLE 157. Brazil Implantable Drug Eluting Balloon Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 158. Brazil Implantable Drug Eluting Balloon Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 159. Brazil Implantable Drug Eluting Balloon Market Size, by End User, 2017-2032 (USD Million)
TABLE 160. Brazil Implantable Drug Eluting Balloon Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 161. United Kingdom Implantable Drug Eluting Balloon Market Size, 2017-2032 (USD Million)
TABLE 162. United Kingdom Implantable Drug Eluting Balloon Market Size, by Indication, 2017-2032 (USD Million)
TABLE 163. United Kingdom Implantable Drug Eluting Balloon Market Size, by De Novo Lesion, 2017-2032 (USD Million)
TABLE 164. United Kingdom Implantable Drug Eluting Balloon Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 165. United Kingdom Implantable Drug Eluting Balloon Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 166. United Kingdom Implantable Drug Eluting Balloon Market Size, by End User, 2017-2032 (USD Million)
TABLE 167. United Kingdom Implantable Drug Eluting Balloon Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 168. Germany Implantable Drug Eluting Balloon Market Size, 2017-2032 (USD Million)
TABLE 169. Germany Implantable Drug Eluting Balloon Market Size, by Indication, 2017-2032 (USD Million)
TABLE 170. Germany Implantable Drug Eluting Balloon Market Size, by De Novo Lesion, 2017-2032 (USD Million)
TABLE 171. Germany Implantable Drug Eluting Balloon Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 172. Germany Implantable Drug Eluting Balloon Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 173. Germany Implantable Drug Eluting Balloon Market Size, by End User, 2017-2032 (USD Million)
TABLE 174. Germany Implantable Drug Eluting Balloon Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 175. France Implantable Drug Eluting Balloon Market Size, 2017-2032 (USD Million)
TABLE 176. France Implantable Drug Eluting Balloon Market Size, by Indication, 2017-2032 (USD Million)
TABLE 177. France Implantable Drug Eluting Balloon Market Size, by De Novo Lesion, 2017-2032 (USD Million)
TABLE 178. France Implantable Drug Eluting Balloon Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 179. France Implantable Drug Eluting Balloon Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 180. France Implantable Drug Eluting Balloon Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. France Implantable Drug Eluting Balloon Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 182. Russia Implantable Drug Eluting Balloon Market Size, 2017-2032 (USD Million)
TABLE 183. Russia Implantable Drug Eluting Balloon Market Size, by Indication, 2017-2032 (USD Million)
TABLE 184. Russia Implantable Drug Eluting Balloon Market Size, by De Novo Lesion, 2017-2032 (USD Million)
TABLE 185. Russia Implantable Drug Eluting Balloon Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 186. Russia Implantable Drug Eluting Balloon Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 187. Russia Implantable Drug Eluting Balloon Market Size, by End User, 2017-2032 (USD Million)
TABLE 188. Russia Implantable Drug Eluting Balloon Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 189. Italy Implantable Drug Eluting Balloon Market Size, 2017-2032 (USD Million)
TABLE 190. Italy Implantable Drug Eluting Balloon Market Size, by Indication, 2017-2032 (USD Million)
TABLE 191. Italy Implantable Drug Eluting Balloon Market Size, by De Novo Lesion, 2017-2032 (USD Million)
TABLE 192. Italy Implantable Drug Eluting Balloon Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 193. Italy Implantable Drug Eluting Balloon Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 194. Italy Implantable Drug Eluting Balloon Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. Italy Implantable Drug Eluting Balloon Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 196. Spain Implantable Drug Eluting Balloon Market Size, 2017-2032 (USD Million)
TABLE 197. Spain Implantable Drug Eluting Balloon Market Size, by Indication, 2017-2032 (USD Million)
TABLE 198. Spain Implantable Drug Eluting Balloon Market Size, by De Novo Lesion, 2017-2032 (USD Million)
TABLE 199. Spain Implantable Drug Eluting Balloon Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 200. Spain Implantable Drug Eluting Balloon Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 201. Spain Implantable Drug Eluting Balloon Market Size, by End User, 2017-2032 (USD Million)
TABLE 202. Spain Implantable Drug Eluting Balloon Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 203. China Implantable Drug Eluting Balloon Market Size, 2017-2032 (USD Million)
TABLE 204. China Implantable Drug Eluting Balloon Market Size, by Indication, 2017-2032 (USD Million)
TABLE 205. China Implantable Drug Eluting Balloon Market Size, by De Novo Lesion, 2017-2032 (USD Million)
TABLE 206. China Implantable Drug Eluting Balloon Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 207. China Implantable Drug Eluting Balloon Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 208. China Implantable Drug Eluting Balloon Market Size, by End User, 2017-2032 (USD Million)
TABLE 209. China Implantable Drug Eluting Balloon Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 210. India Implantable Drug Eluting Balloon Market Size, 2017-2032 (USD Million)
TABLE 211. India Implantable Drug Eluting Balloon Market Size, by Indication, 2017-2032 (USD Million)
TABLE 212. India Implantable Drug Eluting Balloon Market Size, by De Novo Lesion, 2017-2032 (USD Million)
TABLE 213. India Implantable Drug Eluting Balloon Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 214. India Implantable Drug Eluting Balloon Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 215. India Implantable Drug Eluting Balloon Market Size, by End User, 2017-2032 (USD Million)
TABLE 216. India Implantable Drug Eluting Balloon Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 217. Japan Implantable Drug Eluting Balloon Market Size, 2017-2032 (USD Million)
TABLE 218. Japan Implantable Drug Eluting Balloon Market Size, by Indication, 2017-2032 (USD Million)
TABLE 219. Japan Implantable Drug Eluting Balloon Market Size, by De Novo Lesion, 2017-2032 (USD Million)
TABLE 220. Japan Implantable Drug Eluting Balloon Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 221. Japan Implantable Drug Eluting Balloon Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 222. Japan Implantable Drug Eluting Balloon Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. Japan Implantable Drug Eluting Balloon Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 224. Australia Implantable Drug Eluting Balloon Market Size, 2017-2032 (USD Million)
TABLE 225. Australia Implantable Drug Eluting Balloon Market Size, by Indication, 2017-2032 (USD Million)
TABLE 226. Australia Implantable Drug Eluting Balloon Market Size, by De Novo Lesion, 2017-2032 (USD Million)
TABLE 227. Australia Implantable Drug Eluting Balloon Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 228. Australia Implantable Drug Eluting Balloon Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 229. Australia Implantable Drug Eluting Balloon Market Size, by End User, 2017-2032 (USD Million)
TABLE 230. Australia Implantable Drug Eluting Balloon Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 231. South Korea Implantable Drug Eluting Balloon Market Size, 2017-2032 (USD Million)
TABLE 232. South Korea Implantable Drug Eluting Balloon Market Size, by Indication, 2017-2032 (USD Million)
TABLE 233. South Korea Implantable Drug Eluting Balloon Market Size, by De Novo Lesion, 2017-2032 (USD Million)
TABLE 234. South Korea Implantable Drug Eluting Balloon Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 235. South Korea Implantable Drug Eluting Balloon Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 236. South Korea Implantable Drug Eluting Balloon Market Size, by End User, 2017-2032 (USD Million)
TABLE 237. South Korea Implantable Drug Eluting Balloon Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 238. Global Implantable Drug Eluting Balloon Market Share, by Key Player, 2025
TABLE 239. Global Implantable Drug Eluting Balloon Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Alvimedica Medical Technologies Inc.
  • AngioDynamics, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cardionovum GmbH
  • Concept Medical, Inc.
  • ConMed Corporation
  • Cook Medical Incorporated
  • Eurocor GmbH
  • iVascular S.L.U.
  • Koninklijke Philips N.V.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Opto Circuits (India) Ltd.
  • Paladin Medical Pvt. Ltd.
  • Terumo Corporation

Related Topics

Related Reports

Implantable Coronary Drug Eluting Stent Market - Global Forecast 2026-2032 - Product Image

Implantable Coronary Drug Eluting Stent Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Drug Eluting Balloon Market - Global Forecast 2026-2032 - Product Image

Drug Eluting Balloon Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Drug Eluting Balloon Catheter Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Drug Eluting Balloon Catheter Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Drug Eluting Balloons - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Drug Eluting Balloons - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 110 Pages
  • Global
From
Drug-Eluting Balloon Catheters - Global Strategic Business Report - Product Image

Drug-Eluting Balloon Catheters - Global Strategic Business Report

  • Report
  • 279 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.